Treatment of obesity and essential hypertension and related disorders

Garth Cooper; J. S Garth; B Leighton

Treatment of obesity and essential hypertension and related disorders

Garth Cooper (Other)
, J. S Garth (Other)
, B Leighton (Other)

Research output: Patent

Abstract

The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis

Original language	English
Patent number	5364841
Publication status	Published - 15 Nov 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{1bec3ee4038f4b7a808a134274f511ad,

title = "Treatment of obesity and essential hypertension and related disorders",

abstract = "The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis",

author = "Garth Cooper and Garth, \{J. S\} and B Leighton",

note = "Issuing organisation: USPLocation issued: USA; 5364841",

year = "1994",

month = nov,

day = "15",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Treatment of obesity and essential hypertension and related disorders

A2 - Cooper, Garth

A2 - Garth, J. S

A2 - Leighton, B

N1 - Issuing organisation: USPLocation issued: USA

PY - 1994/11/15

Y1 - 1994/11/15

N2 - The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis

AB - The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis

M3 - Patent

M1 - 5364841

ER -

Treatment of obesity and essential hypertension and related disorders

Abstract

UN SDGs

Fingerprint

Cite this